CIK 0001599298
- Large accelerated filer
Summit Therapeutics Inc.
Sign in to watch- Ticker
- SMMT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 371979717
- Phone
- +1 305-203-2034
- Business address
- 601 BRICKELL KEY DRIVE, SUITE 1000, MIAMI, FL, 33131
- Former names
- Summit Therapeutics plc, Summit Corp plc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-26 | Dhingra Ankur Chief Financial Officer | Purchase | +100,000 | $3.75 | $375K | 354,958 |
| 2023-12-13 | Dhingra Ankur Chief Financial Officer | Purchase | +700 | $2.15 | $2K | 235,258 |
| 2023-12-13 | Dhingra Ankur Chief Financial Officer | Purchase | +19,700 | $2.17 | $43K | 254,958 |
| 2023-03-07 | Dhingra Ankur Chief Financial Officer | Purchase | +196,362 | $1.05 | $206K | 234,558 |
| 2022-08-16 | Dhingra Ankur Chief Financial Officer | Purchase | +13,027 | $0.97 | $13K | 39,527 |
| 2022-08-16 | Dhingra Ankur Chief Financial Officer | Purchase | +24,658 | $0.97 | $24K | 38,196 |
| 2022-08-16 | Dhingra Ankur Chief Financial Officer | Purchase | +11,557 | $0.97 | $11K | 38,057 |
| 2022-08-16 | Dhingra Ankur Chief Financial Officer | Purchase | +24,658 | $0.97 | $24K | 38,196 |
| 2022-05-31 | Dhingra Ankur Chief Financial Officer | Grant or award · Stock Option (right to buy) | +600,000 | 600,000 |
Page 1 of 1 · 9 trades